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Abstract
Objective—To evaluate maternal and perinatal outcomes in women undergoing labor induction
with an unfavorable cervix according to duration of oxytocin administration in the latent phase of
labor after ruptured membranes.
Methods—This was a secondary analysis of a randomized multicenter trial in which all cervical
examinations from admission were recorded. Inclusion criteria: nulliparas at or beyond 36 weeks
of gestation undergoing induction with a cervix of 2 cm or less dilated and less than completely
effaced. The latent phase of labor was defined as ending at a cervical dilation of 4 cm and
effacement of at least 90%, or at a cervical dilation of 5 cm regardless of effacement.
Results—One-thousand three-hundred forty-seven women were analyzed. The overall vaginal
delivery rate was 63.2%. Most women had exited the latent phase after 6 hours of oxytocin and
membrane rupture; only 5% remained in the latent phase after 12 hours (n=940, 69.8%). The
longer the latent phase, the lower the vaginal delivery rate. Even so, 39.4% of the 71 women who
remained in the latent phase after 12 hours of oxytocin and membrane rupture were delivered
vaginally. Chorioamnionitis, endometritis, or both, and uterine atony were the only maternal
adverse outcomes related to latent phase duration: adjusted odds ratios (95% confidence intervals)
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of 1.12 (1.07, 1.17) and 1.13 (1.06, 1.19), respectively, for each additional hour. Neonatal
outcomes were not related to latent phase duration.
Conclusion—Almost 40% of the women who remained in the latent phase after 12 hours of
oxytocin and membrane rupture were delivered vaginally. Therefore, it is reasonable to avoid
deeming labor induction a failure in the latent phase until oxytocin has been administered for at
least 12 hours after membrane rupture.
Introduction
In 2006, labor induction was utilized in 22.5% of United States births.1 Despite this high
rate, and despite the fact that among nulliparas, labor induction is associated with a doubling
of the cesarean rate even after controlling for maternal demographic characteristics, medical
risk, and pregnancy complications,2 there is no commonly accepted definition of “failed
labor induction.” Specifically, neither of the two major obstetric textbooks currently in use
in the United States,3,4 nor the ACOG practice bulletin5 on labor induction includes an
explicit definition, although the latter acknowledges that “allowing at least 12-18 hours of
latent labor before diagnosing a failed induction may reduce the risk of cesarean delivery.”
Previously, in a single center prospective study, the utility of a definition of failed labor
induction was evaluated.6 By protocol, the administration of oxytocin for 12 hours after
membrane rupture with no progress into the active phase of labor was required before
induction could be deemed to have failed (n = 940, 69.8%). This requirement allowed
parturients who remained in the latent phase for up to 12 hours to achieve vaginal deliveries
that they otherwise would not have. The utility of this approach was subsequently confirmed
in a retrospective study, also single-centered, in which the majority of women with latent
phase durations of up to 18 hours were delivered vaginally.7 In both of these studies, longer
latent phases were not associated with an increased risk of adverse neonatal outcome.
In the present investigation, we took advantage of data collected as part of multi-centered
fetal pulse oximetry trial8 to evaluate the associated benefits and risks of progressively
longer latent phase durations among nulliparas undergoing labor induction at or beyond 36
weeks’ gestation.
Material and Methods
This was a secondary analysis of a clinical trial of fetal pulse oximetry conducted at the 14
clinical centers of the Eunice Kennedy Shriver National Institute of Child Health and Human
Development Maternal-Fetal Medicine Units Network.8 Participants in that trial were
nulliparas carrying a singleton vertex fetus who were undergoing labor induction or laboring
spontaneously at or beyond 36 weeks’ gestation. To be eligible for randomization and
oximeter placement, the cervix had to be at least 2 cm dilated and the fetal vertex at or
below -2 station. The present analysis was confined to participants who underwent oxytocin
labor induction with an unfavorable cervix, defined as no more than 2 cm dilated and less
than completely effaced, who ultimately met the dilation and station requirements of the
clinical trial. Women were included regardless of their membrane status at the initiation of
induction. Ruptured membranes were required for placement of the fetal pulse oximeter.
However, timing of artificial rupture of membranes was not codified by the study protocol,
but instead was left to the discretion of the managing clinicians. Exclusion criteria for the
trial included maternal fever immediately prior to randomization, infections such as active
genital herpes, HIV, hepatitis B or C, and chronic conditions such as diabetes mellitus, heart
disease treated with medication, and renal disease. Pregnancy-associated hypertension was
not an exclusion criterion. Each participating center had Institutional Review Board
approval for the study.
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Maternal and neonatal data were collected by trained research nurses who were present
throughout labor to adjust the fetal oximeter. They recorded the results of all cervical
examinations, including the time at which they were obtained, into the study database.
Cervical examinations were performed by managing clinicians, not the research nurses. For
this study, the diagnosis of chorioamnionitis required that the clinical diagnosis had been
made, the intrapartum temperature reached at least 38° C, and at least one of the following
was present: uterine tenderness, foul smelling vaginal discharge or amniotic fluid, or
maternal or fetal tachycardia. The study diagnosis of endometritis required a clinical
diagnosis and a post-partum temperature of at least 38° C. Other maternal morbidities were
defined on the basis of clinical diagnoses. Perineal laceration data were collected only for
women who delivered vaginally.
Neonatal morbidities were defined on the basis of clinical diagnoses. In the original trial,8 a
composite outcome of serious neonatal morbidity was defined a priori, and consisted of any
of the following: a 5-minute Apgar score below 4, an umbilical artery pH value under 7.0,
seizures, intubation in the delivery room, stillbirth, neonatal death, or admission to a
neonatal intensive care unit (NICU) for more than 48 hours. Infants who experienced more
than one component of the composite were represented only once in the composite outcome
analysis.
A woman was considered to be in the latent phase of labor until her cervical dilation had
progressed to 4 cm and at least 90% effaced, or to 5 cm regardless of effacement.6 Maternal
and neonatal outcomes were assessed based on the duration of membrane rupture and
concomitant oxytocin receipt in the latent phase of labor. Frequencies are displayed with
three-hour latent phase epochs: < 3 hrs, 3- <6 hrs, 6- <9 hrs, etc.; however all statistical tests,
other than those involving baseline and demographic comparisons, employed a continuous
measure of latent phase duration. Baseline and demographic comparisons between those
with latent phase less than 6 hours compared with 6 hours or more utilized the Wilcoxon
rank-sum test (continuous variables), and the chi-square or Fisher’s exact test (continuous
variables). Associations between duration of the latent phase and the various dichotomous
maternal and neonatal outcomes were analyzed using standard logistic regression, with
adjustment for maternal race and ethnicity, gestational age at delivery, body mass index at
delivery (kg/m2), and study treatment arm (main effects only). All reported P values are
two-sided and a P < 0.05 was considered significant. No adjustments were made for multiple
comparisons. SAS software (SAS Institute, Inc, Cary, NC) was used for analysis.
Results
Of 5,341 parturients enrolled in the clinical trial from May 2002 to February 2005, 1,347
(25.2%) underwent labor induction with a cervix that was no more than 2 cm dilated and
that was less than completely effaced. These 1,347 women and their neonates constitute the
study cohort (Table 1).
The 1220 women who began induction with intact membranes received oxytocin for a
median (range) of 2.8 (0.0, 49.8) hours prior to membrane rupture and their induction to
delivery interval was 16.5 (3.8, 123.1) hours. In 310 (25.4%) of these 1220 women, cervical
ripening was initiated with a prostaglandin 9.0 (0.1, 103.7) hours prior to oxytocin initiation,
in 274 (22.5%) ripening was initiated with a Foley balloon catheter 0.5 (0.0, 30.3) hours
prior to oxytocin initiation, and in 33 (2.7%) ripening was initiated with a prostaglandin and
Foley balloon catheter 12.7 (3.2, 82.6) hours prior to oxytocin initiation. The 122 women
who began induction with ruptured membranes had a median induction to delivery interval
of 15.5 (4.2, 38.3) hours.
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Within six hours after receiving oxytocin with ruptured membranes, most women had
entered the active phase of labor. Women who had not were more likely to be Black or
Hispanic and of higher body mass index, and to have begun induction with a more
unfavorable cervix (all p < 0.01) (Table 1).
The rate of cesarean delivery rose significantly as duration of oxytocin use with ruptured
membranes in the latent phase increased (p < 0.001, logistic regression). Even so, 39.4%
(95% CI, 28.1% to 50.8%) of women who remained in the latent phase after 12 hours of
oxytocin with ruptured membranes were delivered vaginally (Table 2). Rates of
chorioamnionitis and endometritis were positively associated with latent phase duration, as
was uterine atony (Tables 3 and 4). There were no intrapartum or neonatal deaths, and no
cases of hypoxic ischemic encephalopathy. Neonatal morbidities were not associated with
duration of latent phase (Tables 3 and 4). Four infants were diagnosed with bacterial sepsis
in the neonatal period. The durations of the latent phase in these cases ranged from 57
minutes to 7 hours, 5 minutes.
Overall, 57 women, or 4.2% (95% CI, 3.2% to 5.3%), underwent cesarean delivery while
still in the latent phase. Of these, 42 (73.7%) were delivered for “dystocia” and 15 (26.3%)
for non-reassuring fetal status.
Not surprisingly, initial cervical dilation was correlated with the likelihood of both reaching
the active phase, and of delivering vaginally. Of the 1,347 women in our cohort, 774
(57.5%) began induction with a cervix that was no more dilated than one centimeter, and
573 (42.5%) began induction at two centimeters dilation. Women in the former group were
slightly less likely to reach the active phase (94.6% vs. 97.4%, p = 0.01) and also less likely
to deliver vaginally (58.8% vs. 69.1%, p < 0.001).
Discussion
In our cohort of nulliparas who underwent labor induction, we found that almost 40% of
women who remained in the latent phase after 12 hours of oxytocin with ruptured
membranes were delivered vaginally. These data, prospectively collected from 14 centers,
broaden our understanding of the benefits and risks of progressively longer latent phase
durations among nulliparas undergoing labor induction. They are consistent with two prior
single center investigations that showed progressively lower rates of vaginal delivery with
longer durations of the latent phase, and higher rates of associated maternal infection, but no
increase in neonatal morbidity rates.6,7 All three studies report outcomes with the same
reproducible metric (duration of oxytocin administration after membrane rupture) and utilize
a common definition of the latent phase, defined in terms of cervical dilation and
effacement.
The first of the single center studies, by Rouse et al., included 361 nulliparas who underwent
labor induction with an unfavorable cervix at or beyond 36 weeks’ gestation.6 Their overall
cesarean delivery rate was 25%. In their study cohort, 13 of the 15 women (87%) who had
not entered the active phase (cervical dilation of ≥4 cm and effacement ≥90% or cervical
dilation ≥5 cm regardless of effacement) by 12 hours ultimately were delivered by cesarean,
and 27% were diagnosed with chorioamnionitis. No other maternal or neonatal morbidities
were correlated with the duration of the latent phase.
In the second single center study, by Simon and Grobman, 397 nulliparas who underwent
labor induction at 36 weeks’ gestation or greater were evaluated.7 The overall cesarean
delivery rate for these women was 26%. Only 19 women (5%) had latent phase durations
that exceeded 18 hours, and their cesarean delivery rate was 68%. However, 2/3 of the
women with latent phase durations of 15-18 hours were delivered vaginally, and vaginal
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delivery rates were even higher for women with shorter latent phase durations. In addition to
chorioamnionitis, post-partum hemorrhage was correlated with latent phase duration, but
blood transfusion or other maternal or neonatal morbidities were not.
In the present investigation of 1,347 nulliparas, cesarean delivery rates vis-à-vis latent phase
durations were intermediate between the two above studies. For example, in this study,
women with latent phase durations of at least 12 hours had a 61% cesarean delivery rate, as
compared to 87% in the Rouse study and 41% in the Simon and Grobman study. Maternal
infection rates were comparable, and, similar to the increased rate of post-partum
hemorrhage in the Simon and Grobman study, the rate of uterine atony, but not blood
transfusion, was increased in the present investigation as the duration of the latent phase
increased. In all three studies, failure to exit the latent phase after 12 hours of oxytocin and
ruptured membranes was uncommon: 4%,6 17%,7 and 5% (present study).
In a similar study, Blackwell et al. reported that the 50th percentile of latent phase duration
for nulliparas who underwent labor induction and delivered vaginally was 11 hours, and the
90th percentile was 27 hours. In their study, latent phase duration was calculated as the time
from the initiation of cervical ripening until 4 cm of cervical dilation, and this duration was
not correlated with adverse outcomes, either maternal or perinatal.9
The strengths of our data are that they were prospectively accrued, reflect practice patterns
and outcomes from 14 centers, and were collected by trained and certified research nurses
present during labor.
Weaknesses of our data include the fact that labor management was not standardized which
limits the value of the causal implications of the data. That is, the complications that we
observed in association with latent phase duration may not per se be due to duration, or at
least duration alone. Similarly, for several of the complications, our study design does not
allow us to say that the complications would have been avoided if the latent phase had been
shorter. Another potential weakness is that even with a sample size of over 1,300 women,
our statistical power to detect an increased risk of infrequent complications in association
with the duration of the latent phase was low, especially for those who remained in the latent
phase beyond 12 hours. This same limitation applies to all previous studies.6,7,9
A further limitation of our data is that only women who achieved cervical dilations of at
least 2 cm and fetal stations at or below -2 were included in this secondary analysis
(otherwise they would not have been eligible for the parent clinical trial). Thus our data are
not representative of women who undergo induction and do not achieve these thresholds.
Such women, however, are clearly in the minority. In the study of Rouse et al., only 8% of
nulliparas did not progress to the active phase,6 and in the study of Simon and Grobman,
only 2% did not.7 Since 98% of women in the study cohort received epidural analgesia, our
findings may not be generalizable to women who labor without such analgesia. Finally,
since we studied only nulliparous women, our data do not speak to management of
multiparous women.
In conclusion, our data support that the reproducible metrics of duration of oxytocin
administration after membrane rupture, and time in the latent phase may be useful in moving
toward a definition of failed labor induction. Any such definition will involve judgments and
tradeoffs. But pending further study, an argument can be made on the basis of the available
data that requiring at least twelve hours of oxytocin after ruptured membranes before
declaring an induction to have failed in the latent phase reasonably balances maternal
benefits, i.e., the opportunity for vaginal delivery, with maternal risks, specifically
chorioamnionitis and uterine atony. Reassuringly, with contemporary management, any
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fetal/neonatal risks associated with labor induction do not seem to be affected by latent
phase duration.
Acknowledgments
The authors thank Kenneth J. Leveno, M.D. for protocol development and oversight, Elizabeth Thom, Ph.D., for
protocol and data management and statistical analysis, Allison T. Northen, M.S.N., R.N. forprotocol development
and coordination between clinical research centers, and Donald McIntire, Ph.D., for study design.
Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development
(NICHD) [HD21410, HD27860, HD27869, HD27915, HD27917, HD34116, HD34136, HD34208, HD40485,
HD40500, HD40512, HD40544, HD40545, HD40560, and HD36801] and does not necessarily represent the
official views of the NICHD or the NIH.
Appendix
In addition to the authors, other members of the Eunice Kennedy Shriver National Institute
of Child Health and Human Development Maternal-Fetal Medicine Units Network are as
follows:
University of Alabama at Birmingham — A. Northen, K. Bailey, J. Grant, S. Tate, and T.
Hill-Webb
Brown University — J. Tillinghast, D. Allard, P. Breault, N. Connolly, and J. Silva
Case Western Reserve University--MetroHealth Medical Center — C. Milluzzi, C. Heggie,
H. Ehrenberg, and B. Stetzer
Columbia University — V. Pemberton, S. Bousleiman, H. Husami, V. Carmona, and S.
South
Drexel University — M. Talucci, M. Pollock, M. Sherman, C. Tocci, and E. Seltzer
University of North Carolina at Chapel Hill — S. Brody, J. Granados, K. Clark, J. Mitchell,
and K. Dorman
Northwestern University — G. Mallett, N. Cengic, M. Huntley, and T. Triplett
The Ohio State University — F. Johnson, S. Fyffe, and M. Landon
University of Pittsburgh — M. Cotroneo, M. Luce, H. Birkland, M. Bickus, and L.
Creswell-Hartman
The University of Texas Health Science Center at Houston — M.C. Day, F. Ortiz, B.
Figueroa, S. Shaunfield, and M. Messer
University of Texas Southwestern Medical Center — J. McCampbell and L. Moseley
University of Utah — K. Anderson, B. Oshiro (McKay-Dee Hospital), F. Porter
(Intermountain Healthcare), K. Jolley (Utah Valley Regional Medical Center), and A.
Guzman (McKay-Dee Hospital)
Wake Forest University Health Sciences — M. Swain, J. Chilton, C. Leftwich, W. Davido,
and K. Johnson
Wayne State University — G. Norman, B. Steffy, C. Sudz, and S. Blackwell
Rouse et al. Page 6













The George Washington University Biostatistics Center — E.A. Thom, A. Swanson, F.
Galbis-Reig, and L. Leuchtenburg
Eunice Kennedy Shriver National Institute of Child Health and Human Development — S.
Tolivaisa and K. Howell
References
1. Martin, JA.; Hamilton, BE.; Sutton, PD.; Ventura, SJ., et al. Births: Final data for 2006. National
vital statistics reports. Vol. 57. National Center for Health Statistics; Hyattsville, MD: 2009.
2. Ehrenthal DB, Jiang X, Strobino DM. Labor induction and risk of a cesarean delivery among
nulliparous women at term. Obstet Gynecol. 2010; 116:35–42. [PubMed: 20567165]
3. Cunningham, FG.; Leveno, KJ.; Bloom, SL.; Hauth, JC.; Rouse, DJ.; Spong, CY. Williams
Obstetrics. 23rd edition. McGraw Hill; New York (NY): 2009.
4. Gabbe, SG.; Neibyl, JR.; Simpson, JL. Obstetrics: Normal and Problem Pregnancies. 5th edition.
Churchill Livinstone Elsevier; Philidelphia (PA): 2007.
5. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 107 Induction
of Labor. 2009
6. Rouse DJ, Owen J, Hauth J. Criteria for failed labor induction: Prospective evaluation of a
standardized protocol. Obstet Gynecol. 2000; 96:671–7. [PubMed: 11042299]
7. Simon CE, Grobman WA. When has an induction failed? Obstet Gynecol. 2005; 105:705–9.
[PubMed: 15802394]
8. Bloom SL, Spong CY, Thom E, Varner MW, Rouse DJ, Weininger S, et al. Fetal pulse oximetry
and cesarean delivery. N Engl J Med. 2006; 355:2195–202. [PubMed: 17124017]
9. Blackwell SC, Refuerzo J, Chadha R, Samson J. Duration of labor induction in nulliparous women
at term: How long is long enough? Am J Perinatol. 2008; 25:205–209. [PubMed: 18548392]
Rouse et al. Page 7

























Rouse et al. Page 8
Table 1
Maternal Demographic and Intrapartum Characteristics
Length of latent phase
Less than 6 hours
(n = 940)
6 hours or more
(n = 407)
Age (y) 23.9 ± 5.4 23.9 ± 5.6
Race
 Black 280 (29.8) 140 (34.4)
 White 591 (62.9) 207 (50.9)
 Asian 9 (1.0) 5 (1.2)
 Other 60 (6.4) 55 (13.5)
Body mass index (kg/m2)
 Pre-pregnancy 25.8 ± 6.2 27.6 ± 7.1
 Delivery 31.9 ± 6.3 33.7 ± 7.0
Ethnic group
 Hispanic or Latino 135 (14.4) 85 (20.9)
 Not Hispanic or Latino 805 (85.6) 322 (79.1)
Gestational age (wk) 39.9 ± 1.4 39.9 ± 1.5
Indication for labor induction
 Post-term 289 (30.7) 112 (27.5)
 Gestational hypertension 197 (21.0) 74 (18.2)
 Oligohydramnios 85 (9.0) 45 (11.1)
 Premature rupture of membranes 31 (3.3) 54 (13.3)
 Other maternal or fetal indication 154 (16.4) 82 (20.1)
 Elective 184 (19.6) 40 (9.8)
Cervical ripening agents
 Prostaglandin 217 (23.1) 105 (25.8)
 Foley Catheter 202 (21.5) 77 (18.9)
 Both 24 (2.6) 11 (2.7)
 None 497 (52.9) 214 (52.6)
Use of epidural analgesia 917 (97.6) 401 (98.5)
Type of delivery
 Spontaneous 489 (52.0) 168 (41.3)
 Operative vaginal 155 (16.5) 39 (9.6)
 Cesarean 296 (31.5) 200 (49.1)
Initial Cervical Dilation (cm)
 0 120 (12.8) 73 (17.9)
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Length of latent phase
Less than 6 hours
(n = 940)
6 hours or more
(n = 407)
 1 433 (46.1) 249 (61.2)
 2 387 (41.2) 85 (20.9)
Initial Cervical Effacement (%)
 0-25% 184 (19.6) 129 (31.7)
 30-50% 279 (29.7) 155 (38.1)
 60-75% 223 (23.7) 73 (17.9)
 80-90% 232 (24.7) 41 (10.1)
 Unknown 22 (2.3) 9 (2.2)
Data are presented as mean ± standard deviation, or number (percent)
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Table 2






Labor status at end of
interval (for those who
started interval in the
latent phase)
Vaginal Cesarean
0 - <3 hrs Achieved active phase 425/1347 (31.6) 304/425 (71.5) 121/425 (28.5)
Remain in latent phase 918/1347 (68.2) 547/918 (59.6) 371/918 (40.4)
Were delivered in
latent phase
4/1347 (0.3) 0/4 (0.0) 4/4 (100)
Overall 851/1347 (63.2) 496/1347 (36.8)
3 - <6 hrs Achieved active phase 507/918 (55.2) 340/507 (67.1) 167/507 (32.9)
Remain in latent phase 407/918 (44.3) 207/407 (50.9) 200/407 (49.1)
Were delivered in
latent phase
4/918 (0.4) 0/4 (0.0) 4/4 (100)
Overall 547/918 (59.6) 371/918 (40.4)
6 - <9 hrs Achieved active phase 235/407 (57.7) 143/235 (60.9) 92/235 (39.1)
Remain in latent phase 161/407 (39.6) 64/161 (39.8) 97/161 (60.2)
Were delivered in
latent phase
11/407 (2.7) 0/11 (0.0) 11/11 (100)
Overall 207/407 (50.9) 200/407 (49.1)
9 - <12 hrs Achieved active phase 75/161 (46.6) 36/75 (48.0) 39/75 (52.0)
Remain in latent phase 71/161 (44.1) 28/71 (39.4) 43/71 (60.6)
Were delivered in
latent phase
15/161 (9.3) 0/15 (0.0) 15/15 (100)
Overall 64/161 (39.8) 97/161 (60.2)
12 or more hrs Achieved active phase 48/71 (67.6) 28/48 (58.3) 20/48 (41.7)
Were delivered in
latent phase
23/71 (32.4) 0/23 (0.0) 23/23 (100)
Overall 28/71 (39.4) 43/71 (60.6)
Data are presented as proportions (percent)
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Table 3

































0 - <3 hrs 1347 178 (13.2) 78 (9.2) 63 (4.7) 83 (6.2) 44 (3.3) 57 (4.2)
3 - <6 hrs 918 146 (15.9) 55 (10.1) 52 (5.7) 55 (6.0) 31 (3.4) 40 (4.4)
6 - <9 hrs 407 93 (22.9) 24 (11.6) 35 (8.6) 30 (7.4) 15 (3.7) 21 (5.2)
9 - <12 hrs 161 45 (28.0) 6 (9.4) 16 (9.9) 14 (8.7) 7 (4.3) 10 (6.2)
12 or more
hrs
71 22 (31.0) 3 (10.7) 8 (11.3) 7 (9.9) 2 (2.8) 4 (5.6)




Any of the following: a 5-minute Apgar score below 4, an umbilical artery pH under 7.0, seizures, intubation in the delivery room, stillbirth,
neonatal death, or admission to a neonatal intensive care unit for more than 48 hours
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Table 4






Vaginal delivery 0.94 (0.91, 0.97) <0.001 0.94 (0.91, 0.98) 0.001
Chorioamnionitis/
Endometritis 1.13 (1.09, 1.18) <0.001 1.12 (1.07, 1.17) <0.001
Uterine atony 1.13 (1.07, 1.19) <0.001 1.13 (1.06, 1.19) <0.001
NICU admission 1.03 (0.96, 1.09) 0.43 1.03 (0.96, 1.09) 0.46
NICU admission
>48 hours 1.00 (0.92, 1.10) 0.94 1.01 (0.92, 1.10) 0.90
Neonatal
composite# 1.00 (0.93, 1.09) 0.95 1.01 (0.93, 1.10) 0.81
OR = odds ratio, CI = confidence interval
*
1,290 women who achieved the active phase of labor
**
Odds ratios adjusted for maternal race/ethnicity, gestational age at delivery, body mass index at delivery, and study treatment arm
#
Any of the following: a 5-minute Apgar score below 4, an umbilical artery pH under 7.0, seizures, intubation in the delivery room, stillbirth,
neonatal death, or admission to a neonatal intensive care unit for more than 48 hours
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